-
名老中医薛应中大夫在“誉盛堂中医馆盛大开业典礼上的致词
名老中医薛应中大夫在“誉盛堂中医馆盛大开业典礼暨新收弟子入门仪式”上的致词 各位来宾、各位亲友: 大家好! 非常感谢大家能参加誉盛堂中
-
老街腾龙公司注册开户官网流程步骤
老街腾龙公司怎么注册开户【注册官网】【www.fcai339.com】 【微: FAK8689】【企鹅:2567315821】 办理业务需要+以上联系】 【24小时在线】【公司直属客服】【
-
亚马逊气候宣言基金增加对电子垃圾、碳储存和低碳建筑领域初创企业的投资
亚马逊气候宣言基金(Climate Pledge Fund)近日宣布对三家初创企业进行投资,这些企业正将创新技术和新思维应用到应对气候变化危机的多个不同领域中。 自2020年以
-
Fortrea 发布首份企业社会责任报告
达勒姆北卡罗来纳州, Oct. 18, 2024 (GLOBE NEWSWIRE) - 全球领先的合同研究组织 (CRO) Fortrea (Nasdaq: FTRE) 今日宣布发布公司的首份企业社会责任报告,名为
-
Nikkiso Clean Energy & Industrial Gases Group 与 SunLine Transit Agency 携手庆祝加利福尼亚州新建加氢站
特梅库拉,加利福尼亚州, Oct. 18, 2024 (GLOBE NEWSWIRE) - Nikkiso Clean Energy & Industrial Gases (CE&IG) Group 和 SunLine Transit Agency 近日庆祝新的液
-
WillScot to Announce Third Quarter 2024 Results on October 30, 2024
PHOENIX, Oct. 17, 2024 (GLOBE NEWSWIRE) - WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temp
-
Duck Creek Technologies Named a Leader in Gartner® 2024 Magic Quadrant™ for SaaS P&C Insurance C
Recognized for Completeness of Vision and Ability to Execute BOSTON, Oct. 17, 2024 (GLOBE NEWSWIRE) - Duck Creek Technologies, a leading and innovati
-
Bitget Wallet 荣膺应用程序下载量榜亚军,紧追 Binance 之后
Bitget Wallet 用户突破 4000 万,6 个月内增长 100%,成为超越加密货币交易所的 Web3 门户 维多利亚,塞舌尔, Oct. 18, 2024 (GLOBE NEWSWIRE) - 领先的 Web3 非
-
Newest Micetro release unifies network infrastructure management with support for Cisco Meraki
Organizations can optimize their SD-WAN environments by centralizing DHCP for cloud-based applications and remote locations TORONTO, Oct. 17, 2024 (G
-
Bipsync and Dasseti Partner to Streamline Research and Due Diligence Processes for Investment Manage
Asset managers and allocators gain a competitive edge with data collection and research management solutions from Bipsync and Dasseti NEW YORK, Oct.
-
LYB completes acquisition of solvent-based recycling company APK
Company welcomes additional recycling technology to its portfolio Ambition to further develop solvent-based recycling technology and bring to com
-
Bright Peak Therapeutics Announces Dosing of First Patient in Phase 1/2a Clinical Trial of BPT567
Bright Peak Therapeutics Announces Dosing of First Patient in Phase 1/2a Clinical Trial of BPT567, a First-in-Class Bifunctional PD1-IL18 Immunoconjug